[CF Startups Co., Ltd.] Stock investment crowdfunding “CF
Angels”, advance disclosure of project No. 35, recruitment scheduled to start at 9:00 on Monday, August 19th
*CF Startups Co., Ltd.*
Press release: August 13, 2024
**
Stock investment crowdfunding “CF Angels” starts advance disclosure of project No. 35, recruitment is scheduled to start at 9:00 on Monday, August 19th
*NPT Co., Ltd. contributes to society by developing new drugs and treatments using personalized medicine technology to treat cancers that are difficult to cure with conventional holistic treatments* CF Startups Co., Ltd. is an equity investment crowdfunding company operated by CF Startups Co., Ltd. (Headquarters: Shibuya-ku, Tokyo / Representative Director: Hitoshi Usui / hereinafter referred to as the Company).
“Angels” has released information on “NPT Co., Ltd.” as its 35th project. “CF
“Angels” is a stock investment-type crowdfunding service that allows unlisted companies to raise small amounts of funds from many individual investors (angel investors) by recruiting shareholders for their own shares on the website. As the 35th project, we will support “NPT Co., Ltd.”.
Click here for more information about the project
https://cfangels.jp/projects/35
About “NPT Co., Ltd.”
▼Overview
▼Issues to be solved
* Developing “tailor-made immunotherapy” tailored to each cancer patient! * ◆
In Japan, the number of people dying from cancer continues to increase, and the limits of current drug treatments (anticancer drugs, molecular target drugs, immune checkpoint inhibitors, etc.) are becoming clearer.
◆Cancer is said to be caused by genetic mutations. The current uniform treatment approach does not address the genetic diversity of cancer or the differences in immune responsiveness between individuals, so its effectiveness is limited, and its side effects can cause great harm to patients. give.
◆
In order to resolve these issues, the company has developed a new treatment method called the PAPC vaccine, which is a custom-made immune cell therapy tailored to each patient’s condition, overturning the conventional treatment concept. . We will realize medical care in which each individual can receive safe and more effective immune cell therapy.
▼How to solve it
●
The PAPC vaccine is an antigen-presenting cell product made with five types of neoantigen peptides based on a mutated gene (neoantigen) that is specifically expressed in cancer cells of cancer patients. ●
The PAPC vaccine administered intradermally to a patient transmits neoantigen peptide information to killer T cells, and when the activated (proliferates and becomes active) killer T cells find cancer cells that have the same neoantigen peptide, Launch an attack and destroy cancer cells.
● Rather than administering the neoantigen peptide directly into the body, it is unique in that killer T cells can be activated more efficiently by administering it on antigen-presenting cells. ● Since the type of neoantigen differs for each patient, it is possible to provide completely customized treatment suitable for that person.
▼Business model
⇒ Our company conducts clinical trials (clinical trials to receive insurance coverage based on the Pharmaceutical and Medical Devices Act),
⇒ Receive pharmaceutical approval using the early approval system for regenerative medicine products,
⇒ After regulatory approval, the drug will be put on the market as a treatment covered by insurance and developed as a standard treatment in medical settings.
* Investor registration with CF Angels is free. Looking for angel investors* Advance registration is required to apply, so if you have not yet registered as an investor, please complete the registration and screening as soon as possible. If you have not yet registered as an investor, you can register below.
▼Click here for investor registration
https://cfangels.jp/investors/sign_up
*Registration is subject to review.
About stock investment crowdfunding “CF Angels”
A stock investment crowdfunding platform that enables unlisted companies to raise funds. Registered investors can invest in unlisted stocks with a bright future that have passed strict screening by professionals, and can become shareholders in startups from their smartphones.
https://cfangels.jp/
About CF Startups Co., Ltd.
Name: CF Startups Co., Ltd.
First Class Small Amount Electronic Recruitment Dealer Kanto Local Finance Bureau (Kinsho) No. 3000
Member association: Japan Securities Dealers Association
Contract dispute resolution agency: Securities and Financial Products Mediation Consultation Center
Investor Protection Fund: Not enrolled
Representative Director: Hitoshi Usui
Address: 8th floor, MAC Shibuya Building, 15-10 Nanpeidai-cho, Shibuya-ku, Tokyo Capital: 179,990,710 yen
Business details: First class small amount electronic recruitment handling business, special business for qualified institutional investors, consulting business
URL: https://www.cfangels.jp/
*This press release is a document to publicly announce information related to the recruitment of stock investment type crowdfunding “CFAngels”, and is not prepared for the purpose of soliciting investment. Please be sure to carefully check the risks associated with investment before making your decision.
*Click here for information regarding advertisements, etc.
https://cfangels.jp/terms/ads